|
Headlines
Economic Analysis: Does Artificial Cervical Disc Equate to Lower Treatment Costs in Patients with Degenerative Cervical Disc Disease? 
Vincent C. Traynelis, MD, the University of Iowa, during the 76th Annual Meeting of the American Association of Neurological Surgeons in Chicago In July 2007, the PRESTIGE ® cervical disc, a product of Medtronic, became the first and only artificial disc to date approved by the FDA for use in the cervical spine. The PRESTIGE cervical disc underwent an FDA-approved multicenter clinical trial in the United States, concluding in 2005. The PRESTIGE cervical disc is indicated for spinal arthroplasty in skeletally mature patients with degenerative disc disease at one level from C3 to C7, for intractable radiculopathy and/or myelopathy. This is a stainless-steel device with a ball-in-trough design, held in place with bone screws. Overall, from a societal perspective, the net benefit of arthroplasty versus fusion was $5,988 at 2 years postsurgery View cervical disc replacement.
|
|
||||||||||||||
